SHPMY

$7.47+$0.43 (+6.12%)prev close

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

52-week range

$7.04 – $8.32

34% from low

Exchange

OTC Link

ADRC

Change$-2.03

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$298.0B	+3.9%	$0.00	$0.00–$0.00	—	0
2027	$317.1B	+6.4%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Intrinsic value

$29.75

Price

$7.47

Implied upside

+298%

Symbol	Price	Today	Mkt cap	P/E
SHPMYShanghai Pharmaceuticals Holding Co., Ltd	$7.47	+0.00%	$5.5B	—
CNVVFConvaTec Group Plc	$3.10	-5.78%	$6.0B	—
CNVVYConvaTec Group Plc	$12.63	+0.80%	$6.2B	—
DSRLFDiaSorin S.p.A.	$85.47	+0.00%	$4.2B	—
GNGBYGetinge AB (publ)	$25.16	+0.71%	$6.9B	—
GZPHFGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited	$2.34	+0.00%	$6.2B

Source: Financial Modeling Prep · peers by sector/industry

No one on the platform currently holds SHPMY.

Institutions holding (13F)

No tracked institution reports a position in SHPMY as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

TTM yield · 8.03% ($0.60/share)

No one on the platform has traded SHPMY yet.